BHC

6.51

2.68% 0.17

Handel nachbörslich: 6.51

Bausch Health Companies Inc (BHC)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BHC? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$6.34

Offen:

$6.3

24-Stunden-Volumen:

2.52M

Relative Volume:

0.81

Marktkapitalisierung:

$2.43B

Einnahmen:

$10.53B

Nettoeinkommen (Verlust:

$-1.23B

KGV:

-2.0055

EPS:

-3.246

Netto-Cashflow:

$949.99M

1W Leistung:

+4.16%

1M Leistung:

+37.05%

6M Leistung:

+8.68%

1J Leistung:

-13.32%

1-Tages-Spanne:

$6.18

$6.525

1-Wochen-Bereich:

$6.05

$6.535

52-Wochen-Spanne:

$4.33

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Firmenname

Bausch Health Companies Inc

Sektor

Healthcare (1080)

Branche

Drug Manufacturers - Specialty & Generic (87)

Telefon

514-744-6792

Adresse

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Mitarbeiter

20,300

Twitter

Nächster Verdiensttermin

2026-07-29

Neueste SEC-Einreichungen

BHC's Discussions on Twitter

Compare BHC vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BHC Bausch Health Companies Inc	6.51	2.32B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Equal Weight
2024-08-02	Herabstufung	Piper Sandler	Neutral → Underweight
2024-07-10	Eingeleitet	Raymond James	Mkt Perform
2023-09-20	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Herabstufung	TD Cowen	Outperform → Market Perform
2022-07-29	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Herabstufung	Truist	Buy → Hold
2022-07-28	Herabstufung	JP Morgan	Overweight → Neutral
2022-06-13	Fortgesetzt	JP Morgan	Overweight
2021-03-24	Herabstufung	BofA Securities	Neutral → Underperform
2021-02-17	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Herabstufung	Piper Sandler	Overweight → Neutral
2020-09-17	Hochstufung	BofA Securities	Underperform → Neutral
2020-08-24	Bestätigt	H.C. Wainwright	Buy
2020-06-17	Bestätigt	H.C. Wainwright	Buy
2020-04-24	Eingeleitet	Citigroup	Buy
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-01-22	Hochstufung	Wells Fargo	Underweight → Equal Weight
2019-12-12	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-02	Eingeleitet	Goldman	Neutral
2019-10-25	Eingeleitet	Cowen	Outperform
2019-09-12	Eingeleitet	Guggenheim	Buy
2019-08-15	Hochstufung	TD Securities	Hold → Buy
2019-07-19	Eingeleitet	Wolfe Research	Outperform
2019-06-11	Fortgesetzt	Barclays	Overweight
2019-05-13	Hochstufung	JP Morgan	Underweight → Neutral
2019-03-20	Eingeleitet	SunTrust	Buy
2019-01-02	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-11-05	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Hochstufung	Piper Jaffray	Underweight → Neutral

Alle ansehen

Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten

Aug 14, 2026

Bausch Health Companies Inc.: Target Price Consensus and Analysts Recommendations | BVF | CA0717341071 - marketscreener.com

Aug 14, 2026

Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism - kalkine.ca

Aug 14, 2026

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - AOL.com

Aug 14, 2026

Aug 13, 2026

Bausch Health Stock Faces Renewed Pressure as Investor Confidence Weakens - kalkine.ca

Aug 13, 2026

Aug 12, 2026

Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC) - Seeking Alpha

Aug 12, 2026

BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.

Aug 12, 2026

What Is Fuelling Bausch Health (TSX:BHC) Midcap Interest? - Kalkine Media

Aug 12, 2026

Is Bausch Health (TSX:BHC) Finding Sustainable Pharma Momentum? - kalkinemedia.com

Aug 12, 2026

Bausch Health Stock Faces Renewed Pressure as -1.70% Decline Signals Cautious Investor Sentiment - kalkine.ca

Aug 12, 2026

Bausch Health jumps 40% post-Q2 on strong earni... - Pluang

Aug 12, 2026

Aug 11, 2026

Bausch Health Stock Climbs 1.49% as Pharmaceutical Portfolio Strength and Debt Reduction Efforts Boost Investor Confidence - kalkine.ca

Aug 11, 2026

Aug 10, 2026

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - The Motley Fool

Aug 10, 2026

Bausch Health (BHC) Q2 2026 Earnings Call Transcript - AOL.com

Aug 10, 2026

Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - VisionMonday.com

Aug 10, 2026

Aug 08, 2026

Dimensional Fund Advisors LP Raises Position in Bausch Health Cos Inc. $BHC - marketbeat.com

Aug 08, 2026

Aug 06, 2026

Bausch Health CEO joins Bausch + Lomb board of directors By Investing.com - Investing.com South Africa

Aug 06, 2026

Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - BioSpace

Aug 06, 2026

Bausch Health CEO joins Bausch + Lomb board of directors - Investing.com

Aug 06, 2026

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PR Newswire

Aug 06, 2026

Bausch Health requests four new Bausch + Lomb directors with about 87% stake - Stock Titan

Aug 06, 2026

Aug 04, 2026